Results 131 to 140 of about 2,423,946 (178)

Ten tips for the diagnosis and management of nephrotic syndrome. [PDF]

Clin Kidney J
Berke I, Bruchfeld A, Frangou E, Moran SM, Quintana LF, Stevens KI, Teng YKO, Steiger S, Kronbichler A, Mirioglu S.   +9 more
europepmc   +1 more source

Obinutuzumab is effective for refractory primary membranous nephropathy. [PDF]

BMC Nephrol
Zhao N, Chen P, Chen J, Wang B, Tang X, Tang L, Wang Z, Zhang Y.   +7 more
europepmc   +1 more source

Risk prediction of PLA2R-Ab-negative membranous nephropathy: an interpretable multicenter machine learning model. [PDF]

Front Immunol
Qian K, Niu H, Li Y, Yang F, Shi Z, Dang Y, Li Y, Guo J, Li X, Li J.   +9 more
europepmc   +1 more source

Early kinetics of anti-PLA2R-IgG4 predicts rituximab response in membranous nephropathy: a prospective biomarker study. [PDF]

Sci Rep
Chen S, Bian Y, Jia Y, Sun J, Fu R, Zhang Y, He Z, Du X.   +7 more
europepmc   +1 more source

Efficacy of immunosuppressive therapy in low-risk and intermediate- risk idiopathic membranous nephropathy patients : a 2-year follow-up study. [PDF]

BMC Nephrol
Jin Y, Zhang Y, Chen W, Lan L, Chen C, Jiang J, Jiang J.   +6 more
europepmc   +1 more source

The value of proteinuria for the administration of rituximab in patients with PLA2R-associated membranous nephropathy: a single-centre retrospective analysis. [PDF]

Ann Med
Li X, Zhang Y, Xu C, Ke B.
europepmc   +1 more source

MPO-ANCA-associated glomerulonephritis with immune complex deposition and membranous features in a patient with Sjögren's syndrome: a case report. [PDF]

CEN Case Rep
Yamada K, Fukunaga R, Koshida T, Takagi M, Saeki H, Maiguma M, Kobayashi T, Kihara M, Gohda T, Suzuki Y.   +9 more
europepmc   +1 more source

Clinical effect of obinutuzumab in the treatment of idiopathic membranous nephropathy. [PDF]

Am J Transl Res
Ning S, Zhang Q, Shang Z, Liu H.
europepmc   +1 more source